Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's finasteride 5 mg
tablets to Merck's Proscar® 5 mg tablets following a single, oral 5 mg (1 x 5 mg) dose
administration under fasting conditions.